BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 38 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BANQUE PICTET & CIE SA | 6,300,000 | $637,335,229 | 5.59% |
| Wellesley Asset Management | 42,526,167 | $42,983,572 | 3.50% |
| MACKAY SHIELDS LLC | 76,286,000 | $77,072,118 | 2.16% |
| Sonora Investment Management Group, LLC | 10,960,000 | $11,124,717 | 0.93% |
| Lombard Odier Asset Management (Europe) Ltd | 16,354,000 | $16,495,299 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,695,000 | $36,062,832 | 0.70% |
| ZAZOVE ASSOCIATES LLC | 5,150,000 | $5,210 | 0.48% |
| LOOMIS SAYLES & CO L P | 2,051,316 | $177,808 | 0.29% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,030 | 0.26% |
| PIER 88 INVESTMENT PARTNERS LLC | 602,000 | $605,689 | 0.15% |